Shabanzadeh A P, Tassew N G, Szydlowska K, Tymianski M, Banerjee P, Vigouroux R J, Eubanks J H, Huang L, Geraerts M, Koeberle P D, Mueller B K, Monnier P P
1] Toronto Western Research Institute, Genetics and Development Division, KDT 8-418, 60 Leonard Street, Toronto, M5T 2S8 ON, Canada [2] Department of Anatomy, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
1] Toronto Western Research Institute, Genetics and Development Division, KDT 8-418, 60 Leonard Street, Toronto, M5T 2S8 ON, Canada [2] Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Cell Death Dis. 2015 May 7;6(5):e1744. doi: 10.1038/cddis.2015.109.
The dependence receptor Neogenin and its ligand, the repulsive guidance molecule a (RGMa), regulate apoptosis and axonal growth in the developing and the adult central nervous system (CNS). Here, we show that this pathway has also a critical role in neuronal death following stroke, and that providing RGMa to neurons blocks Neogenin-induced death. Interestingly, the Neogenin pro-death function following ischemic insult depends on Neogenin association with lipid rafts. Thus, a peptide that prevents Neogenin association with lipid rafts increased neuronal survival in several in vitro stroke models. In rats, a pro-survival effect was also observed in a model of ocular ischemia, as well as after middle cerebral artery occlusion (MCAO). Treatments that prevented Neogenin association with lipid rafts improved neuronal survival and the complexity of the neuronal network following occlusion of the middle artery. Toward the development of a treatment for stroke, we developed a human anti-RGMa antibody that also prevents Neogenin association with lipid rafts. We show that this antibody also protected CNS tissue from ischemic damage and that its application resulted in a significant functional improvement even when administrated 6 h after artery occlusion. Thus, our results draw attention to the role of Neogenin and lipid rafts as potential targets following stroke.
依赖性受体Neogenin及其配体排斥性导向分子a(RGMa)在发育中和成年中枢神经系统(CNS)中调节细胞凋亡和轴突生长。在此,我们表明该信号通路在中风后的神经元死亡中也起着关键作用,并且向神经元提供RGMa可阻断Neogenin诱导的死亡。有趣的是,缺血性损伤后Neogenin的促死亡功能取决于Neogenin与脂筏的结合。因此,一种阻止Neogenin与脂筏结合的肽在几种体外中风模型中提高了神经元的存活率。在大鼠中,在眼部缺血模型以及大脑中动脉闭塞(MCAO)后也观察到了促存活作用。阻止Neogenin与脂筏结合的处理改善了大脑中动脉闭塞后神经元的存活率和神经网络的复杂性。为了开发中风治疗方法,我们研发了一种人源抗RGMa抗体,该抗体也可阻止Neogenin与脂筏结合。我们表明这种抗体还能保护中枢神经系统组织免受缺血性损伤,并且即使在动脉闭塞6小时后应用,也能带来显著的功能改善。因此,我们的研究结果使人们关注到Neogenin和脂筏作为中风后潜在治疗靶点的作用。